Extending the small-molecule similarity principle to all levels of biology with the Chemical Checker
Open accessAbstract
Small molecules are usually compared by their chemical structure, but there is no unified analytic framework for representing and comparing their biological activity. We present the Chemical Checker (CC), which provides processed, harmonized and integrated bioactivity data on ~800,000 small molecules. The CC divides data into five levels of increasing complexity, from the chemical properties of compounds to their clinical outcomes. In between, it includes targets, off-targets, networks and cell-level information, such as omics data, growth inhibition and morphology. Bioactivity data are expressed in a vector format, extending the concept of chemical similarity to similarity between bioactivity signatures. We show how CC signatures can aid drug discovery tasks, including target identification and library characterization. We also demonstrate the discovery of compounds that reverse and mimic biological signatures of disease models and genetic perturbations in cases that could not be addressed using chemical information alone. Overall, the CC signatures facilitate the conversion of bioactivity data to a format that is readily amenable to machine learning methods.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A broad set of traditional and modern small-molecule descriptors can capture physicochemical properties, 2D/3D structural information, and a priori knowledge of compound bioactivities.
“Likewise, a broad set of traditional and modern small-molecule descriptors are able to capture physicochemical properties, 2D/3D structural information, and even a priori knowledge of compound bioactivities,192,193”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [192]
The Chemical Checker (CC) is the largest collection of small-molecule bioactivity signatures available to date.
“Recently, we integrated the major chemogenomics and drug databases in a single resource named the Chemical Checker (CC), which is the largest collection of small-molecule bioactivity signatures available to date8.”
From Bioactivity descriptors for uncharacterized chemical compounds (2021) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 97 · Cited by 126
Research works printed but not linked: 2
- [88]McInnes L Healy J 2017 IEEE International Conference on Data Mining Workshops (ICDMW) 2017
- [91]Rennie JDM Shih L Teevan J Karger DR International Conference on International Conference on Machine Learning AAAI Press Washington, DC, USA 2003 616 623
- Authors
- Duran-Frigola, M., Pauls, E., Guitart-Pla, O., Bertoni, M., Alcalde, V., Amat, D., Juan-Blanco, T., & Aloy, P.
- Affiliations
- Institute for Research in Biomedicine (ES)
- Institució Catalana de Recerca i Estudis Avançats (ES)
- Corresponding author
- Aloy, Patrick
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2020-05-18
- Volume
- 38
- Issue
- 9
- Pages
- 1087-1096
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC7616951
- OpenAlex
- W3025733956
- Cited by
- 126
- References
- 97
- Citations by year
- 2026: 8 · 2025: 23 · 2024: 18 · 2023: 23 · 2022: 22 · 2021: 24 · 2020: 8
- FWCI
- 9.69
- Type
- journal article
- Language
- en
- Update notices
- correction (2020-05-21)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Topics
- Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biomedical Text Mining and Ontologies
- Keywords
- small molecules, molecular similarity, drug target identification, off-target effects, molecular networks, omics data, growth inhibition, cell morphology, disease models, gene perturbation, drug discovery, library characterization, machine learning
- MeSH terms
- Biological Products, Drug Therapy, Pharmaceutical Preparations, Humans, Databases, Factual, Biomarkers, Pharmacological, Small Molecule Libraries, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review